European Commission to decide whether to investigate Monsanto glyphosate approval influence

The EU's executive body is to say whether it will investigate allegations of undue influence from Monsanto over the EU approval of herbicide glyphosate.

Monsanto is owner and producer of Roundup, a herbicide which contains glyphosate.

In an oral question to be debated on Tuesday 13 June with the European Commission, MEPs say that correspondence from the company, which was recently disclosed, has shed doubt on the credibility of a number of Monsanto-sponsored studies.

The studies were part of the evidence used by the European Food Safety Authority (EFSA) and the European Chemicals Agency (ECHA) to evaluate the safety of glyphosate.

Glyphosate re-registration for 10 years is due to be discussed in late 2017.

The International Research Agency on Cancer has reported that glyphosate could be carcinogenic, a finding which other studies contradict.

Monsanto said: "IARC’s review of glyphosate is just one example of IARC’s flawed processes and unsubstantiated conclusions, and should be disregarded by policymakers. Instead, the European Commission should listen to its own European Food Safety Authority (EFSA) and European Chemicals Agency (ECHA), which joined every other global health and regulatory body that has reviewed glyphosate in determining that glyphosate is not carcinogenic."

Meanwhile, US National Cancer Institute epidemiologist Aaron Blair, chair of the 17 specialists at the International Agency for Research on Cancer which found that glyphosate was a probable carincogenic in 2915, says important unpublished scientific data was not seen by IARC.

Reuters reports that previously unreported court documents from an ongoing US legal case against Monsanto show that Blair knew the unpublished research found no evidence of a link between glyphosate and cancer. In a sworn deposition given in March this year in connection with the case, Blair also said the data would have altered IARC's analysis. He said it would have made it less likely that glyphosate would meet the agency's criteria for its probable carcinogenic finding.

IARC's rules on assessing substances for carcinogenicity say it can consider only published research and this new data, which came from a large American study on which Blair was a senior researcher, had not been published.

Monsanto said the new data on glyphosate could and should have been published in time to be considered by IARC, and that the failure to publish it undermined IARC's classification of glyphosate.

A legal case against Monsanto, taking place in California, involves 184 individual plaintiffs who cite the IARC assessment and claim exposure to Round Up gave them cancer. They allege Monsanto failed to warn consumers of the risks. Monsanto denies the allegations.


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Sign up now
Already registered?
Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Read These Next

Pest & Disease Factsheet - Mealybugs

Pest & Disease Factsheet - Mealybugs

Vines, tomatoes and tropical plants are among those at risk.

Pest & Disease Factsheet - Bacterial and fungal canker

Pest & Disease Factsheet - Bacterial and fungal canker

A wide range of nursery stock can be susceptible to potential damage from various cankers.

Pest & Disease Factsheet - Spider mites

Pest & Disease Factsheet - Spider mites

Defences for protected and outdoor ornamentals.